Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 2234

1.

Temporal and geographical variations in colorectal cancer incidence in Northern Iran 2004-2013.

Hasanpour-Heidari S, Fazel A, Semnani S, Khandoozi SR, Amiriani T, Sedaghat S, Hosseinpoor R, Azarhoush R, Poorabbasi M, Naeimi-Tabiei M, Roshandel G, Bray F, Weiderpass E.

Cancer Epidemiol. 2019 Feb 13;59:143-147. doi: 10.1016/j.canep.2019.02.003. [Epub ahead of print]

PMID:
30771699
2.

Patient preferences on the use of technology in cancer surveillance after curative surgery: A cross-sectional analysis.

Onuma AE, Palmer Kelly E, Chakedis J, Paredes AZ, Tsilimigras DI, Wiemann B, Johnson M, Merath K, Akgul O, Cloyd J, Pawlik TM.

Surgery. 2019 Feb 12. pii: S0039-6060(19)30006-6. doi: 10.1016/j.surg.2018.12.021. [Epub ahead of print]

PMID:
30770135
3.

Airborne metals and polycyclic aromatic hydrocarbons in relation to mammographic breast density.

White AJ, Weinberg CR, O'Meara ES, Sandler DP, Sprague BL.

Breast Cancer Res. 2019 Feb 13;21(1):24. doi: 10.1186/s13058-019-1110-7.

4.
5.

Impact of SSO-ASTRO margin guidelines on reoperation rates following breast-conserving surgery.

Monaghan A, Chapinal N, Hughes L, Baliski C.

Am J Surg. 2019 Jan 17. pii: S0002-9610(18)31296-0. doi: 10.1016/j.amjsurg.2019.01.007. [Epub ahead of print]

PMID:
30739736
6.

High-risk breast cancer surveillance with MRI: 10-year experience from the German consortium for hereditary breast and ovarian cancer.

Bick U, Engel C, Krug B, Heindel W, Fallenberg EM, Rhiem K, Maintz D, Golatta M, Speiser D, Rjosk-Dendorfer D, Lämmer-Skarke I, Dietzel F, Schäfer KWF, Leinert E, Weigel S, Sauer S, Pertschy S, Hofmockel T, Hagert-Winkler A, Kast K, Quante A, Meindl A, Kiechle M, Loeffler M, Schmutzler RK; German Consortium for Hereditary Breast and Ovarian Cancer (GC-HBOC).

Breast Cancer Res Treat. 2019 Feb 6. doi: 10.1007/s10549-019-05152-9. [Epub ahead of print]

PMID:
30725383
7.

Variation in Nonmelanoma Skin Cancer Incidence by Treatment Modality Among Patients Receiving Multiple Kidney Transplants.

Sexton DJ, O'Kelly P, O'Leary E, Murray S, Deady S, Daly F, Egan J, Houlihan DD, McCormick PA, Morris PG, Ni Raghallaigh S, Moloney FJ, O'Neill JP, Conlon PJ.

JAMA Dermatol. 2019 Feb 6. doi: 10.1001/jamadermatol.2018.4660. [Epub ahead of print]

PMID:
30725084
8.

Meeting Report from the joint IARC-NCI international cancer seminar series: a focus on colorectal cancer.

Gunter MJ, Alhomoud S, Arnold M, Brenner H, Burn J, Casey G, Chan AT, Cross AJ, Giovannucci E, Hoover R, Houlston R, Jenkins M, Laurent-Puig P, Peters U, Ransohoff D, Riboli E, Sinha R, Stadler ZK, Brennan P, Chanock SJ.

Ann Oncol. 2019 Feb 5. doi: 10.1093/annonc/mdz044. [Epub ahead of print]

PMID:
30721924
9.

Cost-effectiveness of early cancer surveillance for patients with Li-Fraumeni syndrome.

Tak CR, Biltaji E, Kohlmann W, Maese L, Hainaut P, Villani A, Malkin D, Sherwin CMT, Brixner DI, Schiffman JD.

Pediatr Blood Cancer. 2019 Feb 4:e27629. doi: 10.1002/pbc.27629. [Epub ahead of print]

PMID:
30719841
10.

Re: "Linkage of the ACR National Mammography Database to the Network of State Cancer Registries: Proof of Concept Evaluation by the ACR National Mammography Database Committee".

Miglioretti DL, Lee JM, Kerlikowske K; Breast Cancer Surveillance Consortium.

J Am Coll Radiol. 2019 Feb;16(2):135-136. doi: 10.1016/j.jacr.2018.09.056. No abstract available.

PMID:
30717832
11.

Essential TNM: a registry tool to reduce gaps in cancer staging information.

Piñeros M, Parkin DM, Ward K, Chokunonga E, Ervik M, Farrugia H, Gospodarowicz M, O'Sullivan B, Soerjomataram I, Swaminathan R, Znaor A, Bray F, Brierley J.

Lancet Oncol. 2019 Feb;20(2):e103-e111. doi: 10.1016/S1470-2045(18)30897-0. Review.

PMID:
30712797
12.

Mix methods approach to explore patients' perspectives on the acceptability of a urinary biomarker test in replacement of cystoscopy in bladder cancer surveillance.

Tan WS, Teo CH, Chan D, Heinrich M, Feber A, Sarpong R, Allan J, Williams N, Brew-Graves C, Ng CJ, Kelly JD; DETECT II trial collaborators.

BJU Int. 2019 Jan 29. doi: 10.1111/bju.14690. [Epub ahead of print]

PMID:
30694612
13.

Disparities by province, age, and sex in site-specific cancer burden attributable to 23 potentially modifiable risk factors in China: a comparative risk assessment.

Chen W, Xia C, Zheng R, Zhou M, Lin C, Zeng H, Zhang S, Wang L, Yang Z, Sun K, Li H, Brown MD, Islami F, Bray F, Jemal A, He J.

Lancet Glob Health. 2019 Feb;7(2):e257-e269. doi: 10.1016/S2214-109X(18)30488-1.

14.

Monitoring public health reporting: data tracking in cancer registries.

Jabour AM, Dixon BE.

Online J Public Health Inform. 2018 Dec 30;10(3):e220. doi: 10.5210/ojphi.v10i3.9432. eCollection 2018.

15.

[Some thoughts on cancer registry in China: in the era of big data and informatization].

Wei WW, He J.

Zhonghua Zhong Liu Za Zhi. 2019 Jan 23;41(1):15-18. doi: 10.3760/cma.j.issn.0253-3766.2019.01.004. Chinese.

PMID:
30678412
16.

Differences in colorectal cancer surveillance epidemiology and screening in the WHO European Region.

Altobelli E, Rapacchietta L, Marziliano C, Campagna G, Profeta VF, Fagnano R.

Oncol Lett. 2019 Feb;17(2):2531-2542. doi: 10.3892/ol.2018.9851. Epub 2018 Dec 19.

17.

Detection Rates for Benign and Malignant Diagnoses on Breast Cancer Screening With Digital Breast Tomosynthesis in a Statewide Mammography Registry Study.

Fujii MH, Herschorn SD, Sowden M, Hotaling EL, Vacek PM, Weaver DL, Sprague BL.

AJR Am J Roentgenol. 2019 Jan 23:1-6. doi: 10.2214/AJR.18.20255. [Epub ahead of print]

PMID:
30673339
18.

Self-Care Behaviors of Ovarian Cancer Patients Before Their Diagnosis: Proof-of-Concept Study.

Flanagan JM, Skrobanski H, Shi X, Hirst Y.

JMIR Cancer. 2019 Jan 17;5(1):e10447. doi: 10.2196/10447.

19.

Modern Radiation Further Improves Survival in Non-Small Cell Lung Cancer: An Analysis of 288,670 Patients.

Cheng M, Jolly S, Quarshie WO, Kapadia N, Vigneau FD, Kong FS.

J Cancer. 2019 Jan 1;10(1):168-177. doi: 10.7150/jca.26600. eCollection 2019.

20.

Weighting Non-probability and Probability Sample Surveys in Describing Cancer Catchment Areas.

Iachan R, Berman L, Kyle TM, Martin KJ, Deng Y, Moyse DN, Middleton D, Atienza AA.

Cancer Epidemiol Biomarkers Prev. 2019 Jan 14. pii: cebp.0797.2018. doi: 10.1158/1055-9965.EPI-18-0797. [Epub ahead of print]

PMID:
30642842

Supplemental Content

Loading ...
Support Center